Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020112514 - AN AURORA A KINASE INHIBITOR FOR USE IN THE TREATMENT OF NEUROBLASTOMA

Publication Number WO/2020/112514
Publication Date 04.06.2020
International Application No. PCT/US2019/062718
International Filing Date 22.11.2019
IPC
A61K 31/445 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
44Non-condensed pyridines; Hydrogenated derivatives thereof
445Non-condensed piperidines, e.g. piperocaine
A61P 35/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
CPC
A61K 31/445
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
44Non condensed pyridines; Hydrogenated derivatives thereof
445Non condensed piperidines, e.g. piperocaine
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
Applicants
  • ELI LILLY AND COMPANY [US]/[US]
Inventors
  • DOWLESS, Michele Suzanne
  • GONG, Xueqian
  • STANCATO, Louis Frank
Agents
  • MYERS, James B.
  • MCGRAW, Elizabeth A.
Priority Data
62/773,36730.11.2018US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) AN AURORA A KINASE INHIBITOR FOR USE IN THE TREATMENT OF NEUROBLASTOMA
(FR) INHIBITEUR DE KINASE AURORA A DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DU NEUROBLASTOME
Abstract
(EN)
The present invention provides an inhibitor of Aurora A kinase, Formula (I) illustrated below, or pharmaceutically acceptable salt thereof, for use in treating neuroblastoma.
(FR)
La présente invention concerne un inhibiteur de la kinase Aurora A, de Formule (I) illustrée ci-dessous, ou un sel pharmaceutiquement acceptable de celui-ci, destiné à être utilisé dans le traitement du neuroblastome.
Latest bibliographic data on file with the International Bureau